FIM
DPLO

Freedom Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Freedom Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-21,238
Closed -$440K – 1201
2017
Q3 		$440K Buy
21,238
+2,490
+13% +$42.1K 0.02% 656
2017
Q2 		$277K Sell
18,748
-1,796
-9% -$29.9K 0.02% 821
2017
Q1 		$328K Buy
+20,544
New +$296K 0.02% 717
2016
Q3 		– Sell
-9,413
Closed -$329K – 967
2016
Q2 		$329K Buy
+9,413
New +$296K 0.02% 558

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Freedom Investment Management's DPLO Position: Q4 2017 in Review

Freedom Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 21,238 shares — an estimated $440K sold.

Freedom Investment Management first reported a position in DPLO in Q2 2016 and held it in 4 quarters. The position peaked at $440K in Q3 2017. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • Freedom Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • Freedom Investment Management sold 21,238 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $440K.
  • Freedom Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 4 quarters.
  • Freedom Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $440K in Q3 2017.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on Freedom Investment Management's 13F filing for Q4 2017, filed 25 Jan 2018.